Article
The relative power of SNPs and haplotype as genetic markers for association tests.
Pharmacogenomics - 1 Feb 2001
Bader J S
Abstract excerpt
Identifying the polymorphisms that contribute to disease predisposition and drug response is a major goal of the post-genome era. Single nucleotide polymorphisms (SNPs) in disease-related genes are often used as candidates in the search for causative variations. Association tests based on haplotypes have also been suggested and, at times, have provided greater statistical power than tests based on the underlying...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.